PEN Dec 2024 185.000 put
- Zacks
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies
Penumbra receives the CE Mark approval for Lightning Flash 2.0 and Lightning Bolt 7 in Europe.
- PR Newswire
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced it has secured CE Mark in Europe for the latest computer assisted vacuum thrombectomy (CAVT) technologies – Lightning Flash™ 2.0 and Lightning Bolt™ 7.
- Simply Wall St.
US Exchange: American Healthcare REIT And 2 More Stocks Estimated Below Intrinsic Value
The U.S. stock market has recently faced turbulence, with major indices like the Nasdaq Composite and S&P 500 experiencing significant declines following a disappointing jobs report. Amidst this volatility, investors are increasingly on the lookout for undervalued stocks that offer potential for growth despite broader economic uncertainties. In this context, identifying stocks that are estimated to be below their intrinsic value can be particularly appealing. This article will explore three...
